Advertisement

Topics

Mallinckrodt Stock Lowered to 'Neutral' at UBS Over Persisting Concerns

05:39 EST 13 Nov 2017 | The Street

Click to view a price quote on MNK.

Click to research the Drugs industry.

Original Article: Mallinckrodt Stock Lowered to 'Neutral' at UBS Over Persisting Concerns

NEXT ARTICLE

More From BioPortfolio on "Mallinckrodt Stock Lowered to 'Neutral' at UBS Over Persisting Concerns"

Advertisement
Quick Search
Advertisement
Advertisement